Accolades
Yvette Ostolaza Named to The Lawyer Hot 100 List
January 28, 2026
Yvette Ostolaza, Sidley’s Management Committee Chair, has been named to The Lawyer Hot 100 2026. The annual list recognizes the most influential leaders across the legal sector, highlighting lawyers, barristers, and in-house counsel distinguished by the excellence, impact, and relevance of their work.
The Lawyer noted: “Since taking on the chair role, Ostolaza has presided over a period of sustained momentum, with Sidley surpassing $3bn in global revenues, all while maintaining an active, hands-on client practice.” This recognition underscores Sidley’s position as an elite global law firm.
Yvette’s appointment as Sidley’s Management Committee Chair follows a decades long career of trailblazing accomplishments. Yvette is also one of the country’s leading business litigators and crisis managers, delivering results for clients at each stage of complex, multi-jurisdictional commercial disputes, arbitrations, and corporate investigations.
The Lawyer noted: “Since taking on the chair role, Ostolaza has presided over a period of sustained momentum, with Sidley surpassing $3bn in global revenues, all while maintaining an active, hands-on client practice.” This recognition underscores Sidley’s position as an elite global law firm.
Yvette’s appointment as Sidley’s Management Committee Chair follows a decades long career of trailblazing accomplishments. Yvette is also one of the country’s leading business litigators and crisis managers, delivering results for clients at each stage of complex, multi-jurisdictional commercial disputes, arbitrations, and corporate investigations.
Contacts
*Admitted to practice only in New York and Texas. Not admitted to practice in Florida.
Capabilities
Suggested News & Insights
Sidley Advises Marathon Asset Management on its up to US$1.6 Billion Sale to CVCJanuary 26, 2026Sidley Advises on Market-Defining Cross-Border India Matters in 2025January 12, 2026New U.S. Executive Order Targets Stock Buybacks, Dividends, and Executive Compensation for Underperforming Defense ContractorsJanuary 9, 2026Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025Sidley Represents ABM In Its US$275 Million Acquisition of WGNSTARDecember 17, 2025Sidley Elects 2026 Partnership and Counsel Classes Across Europe and the U.S.December 11, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
